AV1 Group, Inc. Achieves Limited Info Tier on OTCMarkets Toward Overall Transparency, Liquidity and Accessibility


NEW YORK, Dec. 30, 2010 (GLOBE NEWSWIRE) -- AV1 Group, Inc. (AVOP) announces today that OTC Markets has effected Limited Information Tier for AVOP, moving the stock up in terms of transparency and market integrity from its no information tier as reported with its previous owners.

OTC Markets has implemented a strict information reporting system for non-reporting companies and rates them in accordance to transparency elements from Caveat Emptor to Current Information for Pink Sheets companies (http://www.otcmarkets.com/otcguide/investors_market_tiers.jsp).

AVOP's Board is "well aware of the importance in shareholder accessibility and transparency for a stock, especially when it comes to the non-reporting tiers of the OTC. We feel its our duty to get as much information to shareholders as possible and in a timely manner so they make informed decisions on our efforts. Achieving Limited Info Tier on OTC Markets is simply the first step in our initiative to create a strong stock in line with a strong company. We expect 2011 to be an impressively progressive year for AV1 Group and we look forward to releasing details on our recent negotiations in the coming days."

OTC Markets Inc is a privately owned company based in New York that provides a suite of products and services for the U.S. OTC securities market. The company operates electronic quotations, trading, messaging, and information platforms.

Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.


            

Contact Data